Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
22.24B | 21.61B | 21.30B | 20.86B | 21.42B | 22.69B | Gross Profit |
8.88B | 8.58B | 8.65B | 8.80B | 9.22B | 9.56B | EBIT |
593.24M | 483.24M | 726.35M | 785.30M | 1.10B | 900.00M | EBITDA |
990.36M | 1.07B | 1.30B | 1.56B | 1.81B | 1.58B | Net Income Common Stockholders |
373.60M | 294.88M | 367.02M | 531.77M | 750.93M | 583.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.55B | 3.57B | 3.59B | 4.06B | 4.02B | 100.00M | Total Assets |
22.15B | 21.66B | 20.47B | 20.50B | 20.71B | 20.79B | Total Debt |
2.25B | 1.40B | 1.35B | 1.89B | 2.62B | 3.10B | Net Debt |
-1.30B | -2.17B | -2.24B | -2.17B | -1.40B | -629.00M | Total Liabilities |
7.55B | 7.24B | 6.86B | 7.22B | 8.05B | 9.00B | Stockholders Equity |
14.53B | 14.34B | 13.55B | 13.22B | 12.60B | 11.73B |
Cash Flow | Free Cash Flow | ||||
0.00 | 77.75M | 110.78M | 782.55M | 902.55M | 1.56B | Operating Cash Flow |
0.00 | 690.93M | 606.57M | 1.33B | 1.33B | 1.97B | Investing Cash Flow |
0.00 | -581.78M | -581.54M | -564.16M | -472.65M | -474.00M | Financing Cash Flow |
0.00 | -193.24M | -653.30M | -839.57M | -646.77M | -576.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $449.96B | 13.87 | 8.24% | 2.21% | 7.37% | 48.51% | |
69 Neutral | €297.39B | 15.01 | 8.32% | 2.67% | 2.88% | 16.03% | |
65 Neutral | ¥4.59B | 12.17 | 1.95% | 2.94% | 34.83% | ||
63 Neutral | ¥98.72B | 11.78 | 4.32% | -9.78% | -38.63% | ||
63 Neutral | $980.55B | 19.93 | 17.02% | 1.99% | 7.26% | 18.93% | |
60 Neutral | ¥468.57B | ― | -2.52% | 5.12% | 0.38% | -295.54% | |
60 Neutral | $6.85B | 11.57 | 3.09% | 4.18% | 2.37% | -21.38% |